acids in low birth weight infants during the first 3 d of life are limited (2, 3) . Utilization of intravenously infused amino acids has been studied in older and more stable infants by nitrogen balance (4, 5) . However, interpretation of data obtained by the nitrogen balance technique is limited by errors inherent to the method (6) .
In vivo kinetics of individual amino acids have been studied to understand the dynamics of protein metabolism (7) (8) (9) . Leucine, an essential amino acid catabolized mainly in muscle, the body's major protein store, is uniquely suited as a representative amino acid whose kinetics appear to reflect those of whole-body protein turnover, breakdown, and synthesis (8) .
Thus. to provide information on the safety and efficacy of i.v. administration of crystalline amino acids to low birth weight infants during the first 3 d of life. we determined leucine kinetics. nitrogen balance, and various other biochemical indices in these infants.
MATERIALS A N D METHODS
Twenty-three preterm infants (Table 1) with respiratory distress syndrome who were less than 24 h old and required mechanically assisted ventilation and indwelling arterial catheters were enrolled into a controlled trial comparing parenteral glucose versus glucose plus amino acids during the first 3 d of life. The birth weights of all infants were appropriate for gestational age as calculated from the 1 st d of the mother's last menstrual period or. when dates were uncertain, by the method of Ballard c>i 01. (10) . The study protocol was reviewed and approved by the University of Iowa Committee on Research Involving Human Subjects, and written consent was obtained for each subject from one or both parents.
Patients were assigned by envelope randomization to receive a solution containing glucose alone or glucose and amino acids (1.5 g-kg-'.d-', Aminosyn PF. Abbott Laboratories. North Chicago, IL) i.v. within 24 h of birth; infusion of the assigned solution was therefore begun on d 1 of life. The amino acid solution used did not contain premixed cysteine because of poor long-term solubility. A cysteine hydrochloride additive (Cysteine Hydrochloride Injection, Abbott Laboratories) is available for use with this solution. This cysteine additive was omitted inadvertently from the nutrient solutions administered to the first four infants assigned to receive glucose and amino acids. The subsequent seven patients received the amino acid solution plus the cysteine additive (0.5 g cysteine hydrochloride monohydrate/l2.5 g of other amino acids).
No infant received enteral feedings or parenteral lipid emulsion. The amino acid infusions were started at a mean age of 15 h (SD 3). Nutrient solutions were infused i.v. with the use of mechanical pumps. Thermal support was provided with radiant warmers. Weight was determined daily: fluid intake was recorded, and urine volume was measured and recorded. The Nitrogen haluncc~. In boys, urine was collected directly into 15-m L test tubes, whereas in girls a specially constructed metabolic mattress was used. Immediately after each voiding, urine was transferred to a refrigerated storage vessel which contained 0.5 m L of 9 N HCI. At the end of the collection period. the urine was measured in a graduated cylinder and frozen at -20°C. Urine was digested by the micro-Kjeldahl method. and total nitrogen was determined by microdiffusion ( I I ).
Urine was collected between 48 and 72 h of age. In 15 infants. urine collections were of 24 h duration. In eight infants. urine collections were of less than 24 h (6-1 7 h) duration for various technical reasons. Even though some infants had urine collections of less than 24 h. collections of 6 to 12 h have been shown to be accurate estimates of 24-h collections in parenterally fed infants ( 12. 13) .
Nitrogen intake was calculated from the amount of amino acids infused between 48 and 72 h of life using the weight ratio o f nitrogen to amino acids: this ratio was 0.16 17 and 0.1595 for the infants receiving the amino acid solution without and with cysteine. respectively. We calculated nitrogen balance as intake minus urinary excretion. Fecal nitrogen losses were assumed to be negligible because most infants did not produce feces during the period of the balance study. In another study (14) of somewhat older preterm infants (aged 2-5 d ) who were not fed enterally and who received greater parenteral intakes of amino acids than did our infants. mean fecal excretion of nitrogen was reported to be 12 m g kg-' .d-'. Fecal nitrogen excretion by our infants was probably even less.
Lclrc,incj tnctuholi.sm. T o assess whole-body amino acid and protein kinetics, a 4-h leucine tracer study was performed between 68 and 76 h of age while the infant continued to receive the initially assigned glucose or glucose and amino acid solution.
We adapted for use in sick preterm infants the method of leucine kinetics as described by Matthews c.t ul. (15) . Our subjects were mechanically ventilated via endotracheal tubes and had indwelling arterial catheters and therefore provided ready access to expired air and blood without additional placement of intravascular catheters. Leucine kinetic studies were conducted in 16 patients. In all 16 studies. an isotopic plateau of [I-"C]leucine in plasma was achieved. In four of the initial five patients. enrichments of "CO? in breath could not be assessed for technical reasons. We report here results of leucine kinetic studies from 12 infants. These I2 infants were given a priming dose of of L- COz output was continuously measured before and during the 4-h leucine balance study using a closed-circuit computerized indirect calorimeter (MGM/jr. Utah Medical Products. Midvale. UT) (16). Leucine metabolism was determined only in infants without evidence of endotracheal tube leak. Endotracheal tube leak was determined audibly and by measuring the COz concentration in the oropharynx. Infants were excluded if the oropharyngeal COz concentration exceeded 0.03%.
Blood was obtained from a indwelling arterial catheter and quickly placed into a cold vacuum tube (Vacutainer. Becton Dickinson, Rutherford. NJ) containing dry sodium heparin. The blood was immediately centrifuged and the plasma stored at -60°C for later analysis. Blood samples were obtained before administration of the isotope and also 2 10 T o estimate more accurately the whole-body turnover rate of leucine. the plasma enrichment of [I-"CIKIC was used as an index of leucine tracer dilution throughout the entire system ( 1 7. 20) .
The model for leucine metabolism used here has been used by previous investigators ( 1 5, 3 1 ). The model generates the mass equation where Q is the rate of leucinc turnover (or rate of appearance or disappcarancc); S. the rate of leucine incorporation into protein: 0, the rate of leucine oxidation; B, the rate of leucine release from protein: and I. the ratc of influx of exogenous leucine-in this case. zero for the infants infused only with glucose. and the rate of nontracer leucine intake in the infants infused with glucose and amino acids.
Whole-body leucine turnover was calculated tiom the dilution and E,. the [I-"CIKIC enrichment in plasma at isotopic plateau (atoms excess). Plasma KIC enrichment is taken to reflect the dilution of the leucine tracer intracellularly and therefore to represent the appearance rate of unlabeled leucine into the wholebody system ( 1 7. 20) . The rate of 13C02 excretion (F1'COz) was calculated using the following formula:
where FCO* is the C 0 2 production rate (pmol. h-I): EC02, the cnrichrnent of exhaled I3CO2 (atom % excess expressed as a fraction): W, the body weight (kg): and CF, the correction factor that accounts for the percentage of "CO2 temporarily retained by the body. CF was assumed to be 0.98, the mean value reported by Bresson c.t al. (22) for parenterally fed infants.
Leucine oxidation (L,,) was then determined from the rate of excretion of "COz:
where E, is the plasma enrichment of [I-"CIKIC (atoms % excess), because KIC is the direct precursor source of the carbon atom that is first lost during oxidation, and E, is the initial enrichment of L- (23, 24) . From these values, we calculated net protein balance as synthesis minus breakdown.
Statistical anuly.vis. Biochemical and energy intake data were analyzed for within-group differences by the two-tailed t test and for differences between groups by one-way analysis of variance. C-peptide data were analyzed by the Wilcoxon rank sum test. Leucine kinetics and nitrogen balance data were analyzed for within-group differences by one-way analysis of variance, and significant differences were determined post hoe by the t test. p values less than 0.05 were considered significant.
RESULTS
The daily energy intakes for the glucose alone and the glucose and amino acid groups differed significantly on d 2 and 3 ( Table  2) . Infants infused i.v. with glucose alone had a stable intake of energy over the 3-d study period. However, infants given glucose and amino acids had significantly greater intakes of energy on the 2nd and 3rd d of life; the higher energy intakes on d 2 and 3 were entirely due to higher glucose intakes than on d I . The glucose intake in both groups was not dictated by experimental protocol but was adjusted by the treating physicians based on chemical estimates of blood glucose according to standard nurs- 
Plasma ammonia concentrations on the 3rd d of life were similar and ranged from 45 to 90 pmol/L and from 46 to 82 pmol/L for the infants infused i.v. with glucose alone and with glucose and amino acids, respectively (Table 3) .
Serum urea concentrations were similar on d I and d 3 in infants given glucose alone (Table 3) The mean C 0 2 concentrations were similar between groups (Table 3) , as were the ionized calcium, sodium, potassium, and chloride concentrations.
The mean excretion of C-peptide was 17.6 pmol/mg creatinine124 h (SD 1 1.8) and 30.0 pmol/mg creatine/24 h (SD 22.3) for the glucose alone and the glucose and amino acid groups. respectively. This difference was not statistically significant.
The infants that received glucose and amino acids were in positive nitrogen balance (Table 4) Background (baseline) carbon-13 abundance in expired CO2 was not significantly different betweer, the groups: it was -14.12 (SD 0.36) 6/mil in the infants receiving glucose alone and -14.82 (SD 0.75) 6/mil in the infants receiving both glucose and amino acids. The plateau enrichments of plasma [I-"CIKIC and breath I3CO2 and the rates of L-[I-'3C]leucine infusion and "CO2 excretion in breath were determined for each infant (Table 5) . From these data, leucine turnover and oxidation and percentage of leucine turnover oxidized were calculated ( Table 6 ). The mean [l-13C]leucine enrichments 210 and 240 min after the start of the infusion were 3.55 atom % excess (SD 0.87) and 3.58 atoms % excess (SD 0.85), respectively. The mean enrichments of [I-"CIKIC 2 10 and 240 min after the beginning of the i.v. infusion of L-[l-13C]leucine were 3.38 atoms % excess (SD 1.05) and 3.34 atoms % excess (SD 0.8 I), respectively.
Leucine turnover was significantly greater in the infants given glucose and amino acids than in those who received only glucose. The mean rate of leucine oxidation was also significantly greater in the infants infused i.v. with glucose and amino acids than in those infants infused i.v. with glucose alone. The percentage of leucine turnover oxidized was similar in the two groups.
The estimated whole-body protein turnover was significantly greater in the infants infused with both glucose and amino acids (9.8 g. kg-' .d-', SD I .5) than in those infused with glucose alone (6.7 g. kg-' .d-l, SD 0.9). Protein synthesis was significantly increased in the infants infused with glucose and amino acids, whereas protein breakdown and net balance were similar (Table 7) .
DISCUSSION
The i.v. infusion of amino acids (1.5 g.kg-'.d-') in sick low birth weight infants during the first 3 d of life appears to be safe based on the biochemical indices we measured. In addition, we previously (3) found no abnormal elevations of plasma amino acids in preterm infants given this regimen of early amino acid infusion. Low or normal concentrations of all measured plasma amino acids were found despite amino acid supplementation (3). The lack of elevated plasma amino acid concentrations lends further support to the safety of amino acids administered i.v. beginning on the 1st d of life.
It is well known that sufficient nonprotein energy must be consumed to efficiently utilize ingested protein. Although not as well recognized, amino acids modify energy intake by releasing insulin (25.26). which creates a need for more exogenous glucose energy to prevent hypoglycemia. The early infusion of amino acids in preterm infants appears to have altered glucose metabolism, increasing their need for glucose. Previous investigators (26, 27) have shown that preterm infants infused i.v. with amino acids have greater serum insulin concentrations than those infused with glucose alone. Although not statistically significant, urinary C-peptide excretion (a marker for insulin secretion) tended to be greater in our infants receiving glucose and amino acids. Additional work is needed to quantitate the effects of amino acids on insulin secretion in the critically ill low birth weight infant.
The i.v. administration of similar amounts of amino acids (1.5 g. k g -' . d l ) to ill preterm infants has been shown previously (4, 5) to result in positive nitrogen balance despite inadequate energy intake. Our demonstration of positive nitrogen balance in infants infused with amino acids should be interpreted with caution because of the short period of study and the low nonprotein energy intake (6. 28). The metabolic fate of the infused amino acids, moreover, cannot be determined on the basis of nitrogen balance.
Infants infused with cysteine-containing amino acid solution retained a significantly greater amount of infused nitrogen than did infants receiving cysteine-free solution. Moreover, the serum concentration of urea nitrogen increased significantly during the 3-d study period only in the infants who did not receive cysteine. Bodwell (29) has summarized evidence indicating that when proteins of different quality are fed to provide similar nitrogen intakes. animals consuming the protein of lower quality demonstrate higher serum levels of urea nitrogen. Serum concentration of urea nitrogen has been used as an index of the adequacy of the amino acid intake in studies of rats (30) and human adults (3 I) and infants (32-34) during steady state conditions. Hepatic cystathionase activity is extremely low in early fetal life and increases slowly as the fetus reaches term (35) . Snyderman (36) suggested that cystine may be an essential amino acid for the preterm infant, but her data were not presented in sufficient detail to permit thorough review. Previous studies in parenterally fed infants have failed to demonstrate a significant effect of cysteine on nitrogen balance or growth (37. 38) . These studies examined larger and older preterm infants than those in our study.
We speculate that, in infants of less than 32 wk gestation, cystathionase is not present in sufficient quantity during the first 3 d of life to permit adequate conversion of methionine to cysteine. However, sufficient activity may appear with increased gestational age or postnatal age so that exogenous cysteine is no longer essential (39) .
Leucine turnover and oxidation have been studied in term infants (40, 41) with results similar to those in our study of preterm infants infused with glucose alone for 3 d. Frazer and Bier (40) studied four term infants at 4 to 8 h of age, whose mean rate of leucine turnover was 15 1 @mol. kg-'. h-I (SD 28). Denne and Kalhan (4 1 ) measured leucine kinetics in I2 term infants t Mean of two to four samples for plasma and two to eight samples for breath (SD). kg-'. h-I (SD 38). was similar to that in postabsorptive preterm infants (43) but lower than in fed infants (42) . The rate of leucine oxidation in our infants receiving amino acids, 71 pmol.kg-'. h-' (SD 27). was higher than the rate of oxidation found in the infants studied by de Benoist ct ul. (42) and Denne (43) . These rates of leucine oxidation most likely reflect the overall clinical and nutritional status of these infants. An alternative explanation might be that parenterally delivered amino acids are disposed of more rapidly than are those fed enterally.
Our infants infused i.v. with glucose alone had protein turnover rates (6.7 g. kg-' .d-') that were similar to those of the term infants studied by Frazer and Bier (40) and Denne and Kalhan (41) (6.1 g. kg-' .d-I and 6.7 g. kg-' .d-I. respectively). This similarity between term and preterm infants contrasts with the data o f Nissim ot (11. (44) . who found higher protein turnover rates in younger and less mature infants. Our results suggest that protein turnover in infants is influenced by energy and nutrient intake. Despite the period of negative energy balance in our glucosealone group, protein turnover was high as compared with the fisted adult ( 1 5) and was consistent with the findings of Denne and Kalhan (4 1 ).
The rate of protein synthesis was higher in the infants infused i.v. with glucose and amino acids than in the glucose-alone group. Further. the increased rate of protein synthesis coupled with an unchanged rate of protein breakdown resulted in improved protein balance in the infants administered glucose and amino acids. However. the increased rate of protein synthesis seen in the infants infused with glucose and amino acids cannot be attributed solely to the intake of amino acids but may reflect the interactions of increased insulin secretion (45) and glucose intake (46) or the difference in energy intake on d 2 and 3 (Table 2) .
Whole-body protein balance was assessed with leucine kinetics. Infants infused with glucose alone had a mean loss of 1.6 g. kg-'. d-' of endogenous body protein. representing a 5% loss of total body protein during the 3-d study period assuming the same daily loss and assuming that the protein content of a I-kg infant is 94 g (47) . Alternatively. in infants infused with glucose and amino acids (1.5 g.kg-'.d-I), net protein balance was -0.5 g. kg-' .d-'. which represents a 2% loss of total body protein during the 3-d study period. These estimates differ from the data obtained by the nitrogen balance technique. Using urinary nitrogen excretion to estimate protein balance. a 3% loss and a 2% gain of total body protein would have been inferred in our infants infused i.v. with glucose alone and with glucose and amino acids. respectively. This discrepancy is probably due. at least in part. to the tendency of the nitrogen balance technique to overestimate nitrogen retention (6. 28) .
The effects of infused amino acids on protein synthesis and breakdown found in our study using L-[I-'Clleucine (Table 7) are very similar to the results of a similar study recently reported by van Lingen ct a/. (48) using ['5N]glycine.
In summary. early amino acid administration (1.5 g.kg-' .d-') appears to be biochemically safe. An increased rate of wholebody protein synthesis coupled with an unchanged rate of protein breakdown is seen with the administration of amino acids. resulting in improved protein balance. The early administration of amino acids was associated with a greater intake of energy. perhaps as a result of increased insulin secretion. Additional study of the safety and efficacy of infused amino acids in the first days of life is warranted.
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